-
Posted by
Two Blokes Jul 22 -
Filed in
Stock
-
7 views
AstraZeneca PLC (LSE:AZN) has unveiled plans to invest $50 billion in the United States by 2030, marking its largest-ever commitment to a single country and signalling a major boost for domestic drug manufacturing and research. The centrepiece of the investment is a proposed multi-billion-dollar drug manufacturing facility in Virginia, which would be the company's largest single site worldwide.
